RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue

Kobe Reynders, Els Wauters, Matthieu Moisse, Herbert Decaluwe, Paul De Leyn, Stephanie Peeters, Maarten Lambrecht, Kristiaan Nackaerts, Christophe Dooms, Wim Janssens, Johan Vansteenkiste, Diether Lambrechts, Dirk De Ruysscher

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number131
Number of pages8
JournalRadiation Oncology
Volume13
DOIs
Publication statusPublished - 17 Jul 2018

Keywords

  • Targeted treatment
  • NSCLC
  • PD-L1
  • RNA-sequencing
  • DNA METHYLATION
  • GROWTH-FACTOR
  • DOCETAXEL
  • CHEMOTHERAPY
  • METAANALYSIS
  • DIAGNOSTICS
  • INHIBITORS
  • SIGNATURE
  • CARCINOMA
  • NIVOLUMAB

Cite this

Reynders, K., Wauters, E., Moisse, M., Decaluwe, H., De Leyn, P., Peeters, S., Lambrecht, M., Nackaerts, K., Dooms, C., Janssens, W., Vansteenkiste, J., Lambrechts, D., & De Ruysscher, D. (2018). RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue. Radiation Oncology, 13, [131]. https://doi.org/10.1186/s13014-018-1075-1